Live Oak Investment Partners’s GSK GSK Stock Holding History

Live Oak Investment Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Hold	0	–	–	–	249
2024 Q3	–	Hold	0	–	–	–	236
2024 Q2	–	Hold	0	–	–	–	239
2023 Q4	–	Hold	0	–	–	–	243
2023 Q3	–	Hold	0	–	–	–	244
2023 Q2	–	Hold	0	–	–	–	243
2023 Q1	–	Hold	0	–	–	–	227
2022 Q4	–	Hold	0	–	–	–	229

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return